Effect of breast-conserving surgery plus radiotherapy versus mastectomy on breast cancer-specific survival for early-stage contralateral breast cancer

被引:12
作者
Qian, Chao [1 ]
Liang, Yan [2 ]
Yang, Min [3 ]
Bao, Sheng-Nan [2 ]
Bai, Jian-Ling [3 ]
Yin, Yong-Mei [2 ]
Yu, Hao [3 ]
机构
[1] Nanjing Med Univ, Sir Run Run Hosp, Dept Gen Surg, Nanjing, Peoples R China
[2] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, 300 Guangzhou Rd, Nanjing 210029, Peoples R China
[3] Nanjing Med Univ, Sch Publ Hlth, Dept Biostat, 101 Longmian Ave, Nanjing 211166, Peoples R China
基金
中国国家自然科学基金;
关键词
Breast-conserving surgery (BCS); mastectomy; contralateral breast cancer (CBS); survival; BRCA1/2 MUTATION CARRIERS; 20-YEAR FOLLOW-UP; POSTMASTECTOMY RADIOTHERAPY; THERAPY; CHEMOTHERAPY; MORTALITY; IRRADIATION; RECURRENCE; WOMEN;
D O I
10.21037/gs-21-413
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Breast-conserving surgery followed by radiotherapy is recommended in most women with early-stage unilateral breast cancer. However, its role in contralateral breast cancer (CBC) patients remains unclear. This retrospective study aimed to evaluate the breast cancer-specific survival (BCSS) outcomes after breast-conserving surgery plus radiotherapy compared with mastectomy in women with early-stage (T1- 2N0-1M0) CBC. Methods: Data were extracted from the Surveillance, Epidemiology, and End Results database. BCSS was analyzed using the log-rank method, competing risks regression model, and propensity score matching method. Results: A total of 9,336 early-stage CBC patients were included. After multivariable adjustment, no significant difference in BCSS was found between early-stage CBC patients undergoing breast-conserving surgery plus radiotherapy and those undergoing mastectomy [hazard ratio (HR) 1.11, 95% confidence interval (CI): 0.90-1.37, P=0.329]. BCSS was similar in both treatment groups and in the subgroups stratified by age at first primary breast cancer or CBC diagnosis (<= 50, 51-60, and >60 years), time interval between cancers (<0.25, 0.25-4, 5-9, and <= 10 years), stage of first primary breast cancer, T classification of CBC, histology and hormone receptors status of both cancers (all P>0.05). Among patients with N1 disease at CBC diagnosis, breast-conserving surgery plus radiotherapy was associated with a boundary significantly improved BCSS (HR 1.45, 95% CI: 1.00-2.12, P=0.050). Among patients who underwent breast-conserving surgery for first primary cancer, bilateral mastectomy for contralateral cancer did not improve BCSS compared with breast-conserving surgery plus radiotherapy (P>0.05). There was no significant difference in BCSS between breast-conserving surgery plus radiotherapy and mastectomy plus radiotherapy (P>0.05). Stable results were obtained after propensity score matching. Conclusions: Breast-conserving surgery plus radiotherapy did not significantly influence BCSS outcomes of patients with early-stage CBC. Bilateral mastectomy and mastectomy plus radiotherapy did not confer a survival advantage over breast-conserving surgery plus radiotherapy in these patients. Future prospective studies are necessary to expand on these results.
引用
收藏
页码:2978 / +
页数:26
相关论文
共 49 条
[21]   Contralateral breast cancer: molecular differentiation between metastasis and second primary cancer [J].
Janschek, E ;
Kandioler-Eckersberger, D ;
Ludwig, C ;
Kappel, S ;
Wolf, B ;
Taucher, S ;
Rudas, M ;
Gnant, M ;
Jakesz, R .
BREAST CANCER RESEARCH AND TREATMENT, 2001, 67 (01) :1-8
[22]   Postmastectomy Radiotherapy in Patients with pT1-2N1 Breast Cancer Treated with Taxane-Based Chemotherapy: A Retrospective Multicenter Analysis (KROG 1418) [J].
Kim, Yeon-Joo ;
Park, Won ;
Ha, Boram ;
Park, Boram ;
Joo, Jungnam ;
Kim, Tae Hyun ;
Park, In Hae ;
Lee, Keun Seok ;
Lee, Eun Sook ;
Shin, Kyung Hwan ;
Kim, Haeyoung ;
Yu, Jeong Il ;
Choi, Doo Ho ;
Huh, Seung Jae ;
Wee, Chan Woo ;
Kim, Kyubo ;
Park, Kyung Ran ;
Kim, Yong Bae ;
Ahn, Sung Ja ;
Lee, Jong Hoon ;
Kim, Jin Hee ;
Chun, Mison ;
Lee, Hyung-Sik ;
Kim, Jung Soo ;
Cha, Jihye .
CANCER RESEARCH AND TREATMENT, 2017, 49 (04) :927-936
[23]   Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature [J].
Kirova, Youlia M. ;
Savignoni, Alexia ;
Sigal-Zafrani, Brigitte ;
de La Rochefordiere, Anne ;
Salmon, Remy J. ;
This, Pascale ;
Asselain, Bernard ;
Stoppa-Lyonnet, Dominique ;
Fourquet, Alain .
BREAST CANCER RESEARCH AND TREATMENT, 2010, 120 (01) :119-126
[24]   Use of and Mortality After Bilateral Mastectomy Compared With Other Surgical Treatments for Breast Cancer in California, 1998-2011 [J].
Kurian, Allison W. ;
Lichtensztajn, Daphne Y. ;
Keegan, Theresa H. M. ;
Nelson, David O. ;
Clarke, Christina A. ;
Gomez, Scarlett L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (09) :902-914
[25]   Comparison of long-term results between radiotherapy after breast-conserving surgery and postmastectomy radiotherapy in stage T1-2N1M0 breast cancer [J].
Lan, Xiao-Wen ;
Wen, Ge ;
He, Zhen ;
Huang, Jiang-Hua ;
Zou, Xue-Bin ;
Lin, Xiao ;
Tan, Yu-Ting ;
Huang, Xiao-Bo .
CANCER MANAGEMENT AND RESEARCH, 2019, 11 :6477-6487
[26]   Mortality after contralateral breast cancer in Denmark [J].
Langballe, Rikke ;
Frederiksen, Kirsten ;
Jensen, Maj-Britt ;
Andersson, Michael ;
Cronin-Fenton, Deirdre ;
Ejlertsen, Bent ;
Mellemkjaer, Lene .
BREAST CANCER RESEARCH AND TREATMENT, 2018, 171 (02) :489-499
[27]  
Lee Misa M., 1999, Breast J, V5, P36, DOI 10.1046/j.1524-4741.1999.005001036.x
[28]   Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2 [J].
Ligtenberg, MJL ;
Hogervorst, FBL ;
Willems, HW ;
Arts, PJW ;
Brink, G ;
Hageman, S ;
Bosgoed, EAJ ;
Van der Looij, E ;
Rookus, MA ;
Devilee, P ;
Vos, EMAW ;
Wigbout, G ;
Struycken, PM ;
Menko, FH ;
Rutgers, EJT ;
Hoefsloot, EH ;
Mariman, ECM ;
Brunner, HG ;
Van't Veer, LJ .
BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) :1475-1478
[29]   Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials [J].
McGale, P. ;
Taylor, C. ;
Correa, C. ;
Cutter, D. ;
Duane, F. ;
Ewertz, M. ;
Gray, R. ;
Mannu, G. ;
Peto, R. ;
Whelan, T. ;
Wang, Y. ;
Wang, Z. ;
Darby, S. .
LANCET, 2014, 383 (9935) :2127-2135
[30]   Cancer treatment and survivorship statistics, 2019 [J].
Miller, Kimberly D. ;
Nogueira, Leticia ;
Mariotto, Angela B. ;
Rowland, Julia H. ;
Yabroff, K. Robin ;
Alfano, Catherine M. ;
Jemal, Ahmedin ;
Kramer, Joan L. ;
Siegel, Rebecca L. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2019, 69 (05) :363-385